363
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress

, , , , , & show all
Pages 856-866 | Received 08 Apr 2013, Accepted 19 Aug 2013, Published online: 02 Sep 2013

References

  • Alkilany AM, Murphy CJ. 2010. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 12:2313–2333.
  • Arnida Janat-Amsbury MM, Ray A, Peterson CM, Ghandehari H. 2011. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophage. Eur J Pharm Biopharm 77:417–423.
  • Bischof JC, Goel R, Paciotti GF, Shah N, Visaria R. 2009. Biodistribution of TNF-[alpha]-coated gold nanoparticles in an in vivo model system. Nanomedicine 4:401–410.
  • Cai J, Jones DP. 1998. Superoxide in apoptosis: mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273:11401–11404.
  • Chen YS, Hung YC, Lin LW, Liau I, Hong MY, Huang GS. 2010. Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles. Nanotechnology 21(48):485102.
  • Cho WS, Cho W, Jeong J, Choi M, Han BS, Shin HS, et al. 2010. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245:116–123.
  • Craig ZR, Wang W, Flaws JA. 2011. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction 142:633–646.
  • Diemer T, Allen JA, Hales KH, Hales DB. 2003. Reactive oxygen disrupts mitochondria in MA-10 tumor leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology 144:2882–2891S.
  • Esch RK, Han LI, Karin K, Foarde KK, Ensor SD. 2010. Endotoxin contamination of engineered nanomaterials. Nanotoxicology 4:73–83.
  • Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. 2013. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol 35:67–71.
  • Gao G, Yuguan Z, Bing L, Zhao X, Zhang T, Sheng L, et al. 2012. Ovarian dysfunction and gene-expression characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J Hazard Mater 243:19–27.
  • Gao W, Xu K, Ji L, Tang B. 2011. Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol Lett 205:86–95.
  • Hamada T, Watanabe G, Kokuho T, Taya K, Sasamoto S, Hasegawa Y, et al. 1989. Radioimmunoassay of inhibin in various mammals. J Endocrinol 122:697–704.
  • Harper SL, Carriere JL, Miller JM, Hutchinson JE, Maddux BLS, Tanguay RL. 2011. Systemic evaluation of nanomaterials toxicity: utility of standardized materials and rapid assays. ACS Nano 5:4688–4697.
  • Haseman JK, Bailer AJ, Kodell RL, Morris R, Portier K. 2001. Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61:201–210.
  • Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, et al. 2010. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7:36.
  • Ho HM, Oshima K, Watanabe G, Taya K, Strawn EY, Hutz RJ. 2006. TCDD increases inhibin A production by human luteinized granulosa cells in vitro. J Reprod Dev 52:523–528.
  • Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, et al. 2011. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37:299–309.
  • Hutz RJ, Carvan MJ, Baldridge MG, Conley LK, Heiden TK. 2006. Environmental toxicants and effects on female reproductive function. Tren Reprod Bio 2:1–11.
  • Kessler R. 2011. Engineered nanoparticles in consumer products. Environ Health Perspect 119:a120–a125.
  • Khlebtsov N, Dykman L. 2011. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40:1647–1671.
  • Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, Plech A. 2006. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 110:15700–15777.
  • Larios-Rodriguez E, Rangel-Ayon C, Castillo SJ, Zavala G, Herrera-Urbina R. 2011. Bio-synthesis of gold nanoparticles by human epithelial cells, in vivo. Nanotechnology 22:355601.
  • Li JJ, Lo SL, NG CT, Gurung RL, Hartono D, Hande MP, et al. 2011. Genomic instability of gold nanoparticles treated human lung fibroblast cells. Biomaterials 32:5515–5523.
  • Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, et al. 2010. Phase 1 and pharmacokinetic studies of CYT-6091, a novel PEGlyated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16:6139–6149.
  • Lui X, Qin D, Cui Y, Chen L, Li H, Chen Z, et al. 2010. The effect of calcium phosphate nanoparticles on hormone production and apoptosis in human granulosa cells. Reprod Biol Endocrinol 8:32.
  • Miller MC 3rd, Mohrenweiser HW, Bell DA. 2001. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120:269–280.
  • Monopoli MP, Aberg C, Salvati A, Dawson A. 2012. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–786.
  • Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8.
  • Ngo YH, Li D, Simon GP, Garnier G. 2011. Paper surfaces functionalized by nanoparticles. Adv Colloid Interface Sci 163:23–38.
  • Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
  • Shumyantseva VV, Carrara S, Bavastrello V, Riley JD, Skryabin KG, Archakov AI, et al. 2005. Direct electron transfer between cytochrome P450scc and gold nanoparticles on screen-printed rhodium-graphite electrodes. Biosens Bioelectron 21:217–222.
  • Stelzer RV, Hutz RJ. 2009. Gold nanoparticles enter rat ovarian granulosa cells and subcellular organelles, and alter in-vitro estrogen accumulation. J Reprod Develop 55:685–690.
  • Sung JH, Ji JH, Park JD, Song MY, Song KS, Hyeon RR, et al. 2011. Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 8:16.
  • Taylor CC, Terranova PF. 1996. Lipopolysaccharide inhibits in vitro luteinizing hormone-stimulated rat ovarian granulosa cell estradiol but not progesterone secretion. Biol Reprod 54:1390–1396.
  • Trkulja V, Lackovic Z. 2001. Vagal Influence on compensatory ovarian growth is important only briefly after hemicastration. Exp Biol Med 226:776–781.
  • Truong L, Tilton SC, Zaikova T, Richman E, Waters KM, Hutchinson JE, et al. 2012. Surface functionalities of gold nanoparticles impact embryonic gene expression responses. Nanotoxicol Early Online 1–10. DOI: 10.3109/17435390.2011.648225.
  • Tsai CY, Lu SL, Hu CW, Yeh CS, Lee GB, Lei HY. 2012. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188:68–76.
  • Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee D-H, et al. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378–455.
  • Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple control genes. Genome Biol 3:research0034.1–researc0034.11.
  • Wang J, Zhu X, Zhang X, Zhao Z, Liu H, George R, et al. 2011. Disruption of zebrafish (Danio rerio) reproduction upon chronic exposure to TiO2 nanoparticles. Chemosphere 83:461–467.
  • Woodrow Wilson International Center for Scholars: A nanotechnology consumer products inventory 2012. Available at http://www.nanotechproject.org/consumerproducts. Accessed on 1 March 2013.
  • Yin R, Tian F, Frankenberger B, de Angelis MH, Stoeger T. 2010. Selection and evaluation of stable housekeeping genes for gene expression normalization in carbon nanoparticle-induced acute pulmonary inflammation in mice. Biochem Biophys Res Commun 399:531–536.
  • Young JM, McNeilly AS. 2012. Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells. J Mol Endocrinol 48:49–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.